KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBITDA (2018 - 2025)

Historic EBITDA for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.5 million.

  • Twist Bioscience's EBITDA rose 400.37% to -$30.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.5 million, marking a year-over-year increase of 6125.2%. This contributed to the annual value of -$77.8 million for FY2025, which is 6269.64% up from last year.
  • Per Twist Bioscience's latest filing, its EBITDA stood at -$30.5 million for Q4 2025, which was up 400.37% from -$26.9 million recorded in Q3 2025.
  • Twist Bioscience's EBITDA's 5-year high stood at $20.2 million during Q2 2025, with a 5-year trough of -$85.6 million in Q2 2024.
  • Its 5-year average for EBITDA is -$43.1 million, with a median of -$42.9 million in 2022.
  • In the last 5 years, Twist Bioscience's EBITDA tumbled by 6878.31% in 2021 and then soared by 12357.14% in 2025.
  • Quarter analysis of 5 years shows Twist Bioscience's EBITDA stood at -$45.4 million in 2021, then grew by 5.12% to -$43.1 million in 2022, then increased by 0.56% to -$42.8 million in 2023, then grew by 25.91% to -$31.7 million in 2024, then rose by 4.0% to -$30.5 million in 2025.
  • Its last three reported values are -$30.5 million in Q4 2025, -$26.9 million for Q3 2025, and $20.2 million during Q2 2025.